Traditional protein engineering is a slow, trial-and-error process limited by natural sequence space. Our generative AI systems bypass this bottleneck, creating novel, stable, and functional protein sequences with desired properties from first principles.
Service
Generative Protein Design Engineering

The Challenge of Novel Protein Discovery
Accelerate therapeutic and industrial innovation by moving from protein prediction to AI-driven de novo design.
We architect AI workflows that generate, simulate, and prioritize candidates, reducing discovery cycles from years to months and delivering lab-validated leads.
- De Novo Sequence Generation: Leverage models like ProteinMPNN and RFdiffusion to design proteins for specific binding, catalysis, or stability targets.
- In Silico Validation: Use molecular dynamics simulations and AlphaFold2 structure prediction to computationally screen for expression viability and function before synthesis.
- Multi-Property Optimization: Simultaneously optimize for thermostability, solubility, and low immunogenicity using multi-objective reinforcement learning.
This capability is foundational for developing new therapeutics, industrial enzymes, and diagnostic tools. Explore our related work in Generative AI for Enzyme Engineering and AI for Biomolecular Structure Prediction.
Business Outcomes of AI Protein Design
Move beyond academic prediction to de novo creation of functional proteins. Our engineering service delivers validated, production-ready protein sequences that directly translate into therapeutic, industrial, and diagnostic applications.
Accelerated Therapeutic Discovery
Generate novel, stable protein candidates for biologics, enzymes, and vaccines in weeks, not years. We engineer sequences with optimized binding affinity, solubility, and immunogenicity profiles, de-risking your preclinical pipeline. Learn more about our approach to AI-driven drug discovery.
Industrial Enzyme Optimization
Design enzymes with enhanced catalytic activity, thermal stability, and substrate specificity for green chemistry and biomanufacturing. Our generative workflows create variants tailored to your process conditions, delivering measurable improvements in yield and efficiency. Explore our specialized generative AI for enzyme engineering.
De Novo Diagnostic & Sensor Design
Create entirely new protein-based biosensors and diagnostic reagents with high specificity and low cross-reactivity. We generate binding domains for novel epitopes or non-immunogenic tags, enabling next-generation point-of-care and lab-based assays.
Reduced R&D Costs & Risk
Shift from expensive, iterative wet-lab screening to AI-driven in silico design. Our platform prioritizes synthesizable, expressible sequences with high predicted functionality, dramatically reducing the number of physical experiments required for validation.
IP-Generating Novelty
Secure strong, defensible intellectual property with protein sequences that are novel, non-obvious, and have demonstrable utility. Our generative models explore vast, untapped regions of protein space to deliver compositions not found in nature.
Typical Development Timeline & Deliverables
A clear roadmap for developing a custom generative protein design system, from initial concept to a validated, production-ready AI model.
| Phase & Key Activities | Timeline | Core Deliverables | Client Involvement |
|---|---|---|---|
Discovery & Problem Scoping | 1-2 weeks | Technical requirements document, data readiness assessment, success metrics definition | Provide domain experts, access to legacy data, define target protein properties |
Data Pipeline & Featurization Engineering | 2-3 weeks | Cleaned, annotated training dataset, scalable ETL pipeline, molecular feature library | Approve data schemas, provide feedback on feature relevance |
Model Architecture Design & Initial Training | 3-4 weeks | Customized model architecture (e.g., ProteinMPNN/ESM-2 variant), initial performance benchmarks | Review architectural choices, validate biological plausibility of early outputs |
Iterative Optimization & In-Silico Validation | 4-6 weeks | Fine-tuned model, stability/functionality predictions, generated sequence library (1000s of candidates) | Prioritize candidate sequences for wet-lab testing, provide feedback on failure modes |
Deployment & Integration (MLOps) | 2-3 weeks | Containerized inference API, model monitoring dashboard, integration documentation | Provide staging environment, approve deployment architecture |
Ongoing Support & Model Refinement | Ongoing (Optional SLA) | Monthly performance reports, retraining pipelines, access to model updates | Share wet-lab validation results, identify new design objectives |
Industry Applications & Use Cases
Our generative protein design engineering services translate advanced AI into validated, functional proteins that accelerate R&D timelines and de-risk therapeutic and industrial development. We focus on delivering lab-ready sequences with measurable outcomes.
Novel Therapeutic Protein Design
De novo generation of stable, high-affinity antibody candidates, cytokine variants, and enzyme therapeutics with optimized pharmacokinetic properties. We deliver sequences pre-validated for expression yield and structural stability, reducing early-stage discovery cycles from months to weeks.
Learn more about our approach to AI-Driven Drug Discovery Platform Development.
Industrial Enzyme Optimization
AI-driven engineering of enzymes for enhanced catalytic activity, thermostability, and substrate specificity in biomanufacturing, bioremediation, and green chemistry. Our models predict mutations that achieve target performance metrics, bypassing costly high-throughput screening.
This work is complemented by our dedicated Generative AI for Enzyme Engineering service.
Diagnostic & Biosensor Protein Engineering
Design of highly specific protein binders and reporters for point-of-care diagnostics, in vivo imaging, and environmental monitoring. We generate proteins with tailored binding kinetics and fusion compatibility for integration into sensor platforms.
De Novo Protein Scaffold Creation
Generation of entirely novel protein folds and scaffolds not found in nature, creating blank-slate platforms for multi-specific biologics, drug delivery vehicles, and advanced biomaterials. This unlocks functionality beyond the constraints of natural protein families.
Vaccine Antigen & Immunogen Design
Computational design of immunogens that elicit potent and broad neutralizing antibody responses against viral pathogens and cancers. Our AI models optimize for structural mimicry of native epitopes while enhancing stability and manufacturability.
Protein-Protein Interaction Inhibitors
Rational design of peptides and miniproteins that disrupt pathogenic protein-protein interactions (PPIs) considered 'undruggable' by small molecules. Our generative models explore conformational space to identify tight-binding interfaces.
This often leverages insights from our Graph Neural Network Solutions for Biological Networks.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Frequently Asked Questions on AI Protein Design
Common questions from CTOs and R&D leaders about partnering with Inference Systems for generative protein design projects.
Our standard engagement delivers a shortlist of high-confidence, novel protein sequences in 4-6 weeks. This includes data pipeline setup, model fine-tuning or training, and in-silico validation (stability, solubility, function prediction). Lab validation partnerships extend the timeline based on experimental throughput, but we architect the computational workflow for rapid iteration.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us